[1]
2018. Sonidegib Duration of Response in Advanced Basal Cell Carcinoma: Long-term Results from the Phase 2 BOLT Trial. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S50. DOI:https://doi.org/10.25251/skin.2.supp.50.